Loomis, Sayles & Company’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Sell
54,702
-402,071
-88% -$18.8M ﹤0.01% 459
2026
Q1
$16.5M Buy
456,773
+8,579
+2% +$359K 0.02% 267
2025
Q4
$21.1M Buy
448,194
+83,971
+23% +$3.55M 0.03% 228
2025
Q3
$11.8M Buy
364,223
+30,583
+9% +$1.09M 0.01% 326
2025
Q2
$13.7M Buy
333,640
+110,509
+50% +$4.27M 0.02% 303
2025
Q1
$9.31M Buy
+223,131
New +$11.6M 0.01% 365
2022
Q1
Sell
-3,979
Closed -$334K 1009
2021
Q4
$334K Buy
+3,979
New +$319K ﹤0.01% 530
2017
Q3
Sell
-409
Closed -$12K 922
2017
Q2
$12K Buy
+409
New +$10.5K ﹤0.01% 790
2017
Q1
Sell
-944
Closed -$20K 965
2016
Q4
$20K Buy
+944
New +$20.6K ﹤0.01% 781

Other funds holding BRKR

Loomis, Sayles & Company's BRKR Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Bruker (BRKR) stake by 88% in Q2 2026, selling an estimated $18.8M and leaving 54,702 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #459.

Loomis, Sayles & Company first reported a position in BRKR in Q4 2016 and has held it in 9 quarters since. The position peaked at $21.1M in Q4 2025. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Loomis, Sayles & Company held 54,702 shares of Bruker worth $3.29M as of Q2 2026.
  • Loomis, Sayles & Company sold 402,071 Bruker shares in Q2 2026, an estimated $18.8M.
  • Bruker made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #459 holding.
  • Loomis, Sayles & Company first reported a position in Bruker in Q4 2016 and has held it in 9 quarters since.
  • Loomis, Sayles & Company's Bruker position peaked at $21.1M in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.